GSHD Goosehead Insurance, Inc. Insider Trading

10% Owner Ryan buys 2,800 GSHD shares at $35.56; now holds 7,800 shares (+56.0%). Stock down -67.6% from 52-week high, cluster pattern with 2 other insiders in 14 days.

Langston Patrick Ryan, a 10% owner of Goosehead Insurance, purchased 2,800 shares at $35.56 on 2026-05-29, increasing his stake by 56.0% to 7,800 shares. This transaction coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. The stock is currently trading at $36.65, representing a -67.6% decline from the 52-week high of $113.00 and a -29.9% decline over the past 90 days. Despite the recent weakness, the company's fundamentals remain intact with annual revenue growth of +16.2%, a P/E of 25.45, and most recent quarterly revenue of $93.1M. The convergence of multiple insider purchases at a depressed price point relative to recent highs warrants investor attention to whether this reflects conviction in stabilized fundamentals or simply price-level accumulation.

CFO John Arthur Martin purchases 5,000 shares of GSHD at $34.73; stock down 69.6% from 52-week high; cluster of 2 other insider buys in past 14 days

John Arthur Martin, the Chief Financial Officer, acquired 5,000 shares at $34.73 on 2026-05-28 for a total value of $173,650.00, establishing a new position in the company. The purchase occurs amid significant price deterioration: the stock is -69.6% from its 52-week high of $113.00, down 27.2% over 30 days and 36.6% over 90 days. This buy arrives within a cluster pattern where 2 other insiders also purchased within the past 14 days, suggesting coordinated response to depressed valuation. The company's fundamentals remain positive (16.2% annual revenue growth, $93.1M quarterly revenue, P/E 23.88), establishing a backdrop where insiders are acquiring despite significant recent price weakness.

Executive Chairman trust sold 45.6K GSHD shares ($1.8M) at $40.07; stock down 64.6% from 52-week high, insider's prior 5 sales at this ticker all showed negative 90d returns.

Mark & Robyn Jones Descendants Trust 2014 (Executive Chairman) sold 45,588 shares of Goosehead Insurance at $40.07 on 2026-05-26, with the stock now trading 64.6% below its 52-week high of $113.00. The insider's prior 5 trades at GSHD all showed negative 90-day returns ranging from -19.4% to -22.7%, indicating a consistent pattern of well-timed exits before further declines. The current 30-day decline of -17.1% and 90-day decline of -21.8% align with this historical pattern at the ticker. The company maintains solid fundamentals (revenue $93.1M, P/E of 27.78, annual growth of 16.2%), but the sharp stock price deterioration and the insider's demonstrated track record of exiting before further weakness warrant investor attention to the disconnect between operational health and market valuation.

Mark & Robyn Jones Descendants Trust sold 82,689 shares at blended $41.77, completing 2 separate transactions for $3,453,750.36

Mark & Robyn Jones Descendants Trust 2014, as Executive Chairman, executed 2 separate sales totaling 82,689 shares for $3,453,750.36 on 2026-05-22 at a blended average price of $41.77. The current stock price is $42.49, down -63.0% from the 52-week high of $114.76. Notably, this insider's prior sales at GSHD show a 100% well-timed rate, with 5 of 5 prior sells followed by negative 90-day returns ranging from -19.4% to -22.7%, and this filing involves a derivative-conversion transaction where the insider's complete economic position resides in Form 4 Table II derivative securities not yet populated in the database. The recent -4.9% 30-day and -4.4% 90-day price declines, combined with the company's solid fundamentals (revenue $93,076,000.00, net income $4,889,000.00, +16.2% annual growth, P/E 29.51), warrant observation of how the stock reacts post-transaction and whether the historical pattern of well-timed exits continues.

Executive Chairman's trust sold 70,751 shares ($2.9M) at $40.62–$42.21 on 2026-05-21; stock now -63.0% from 52-week high.

The Mark & Robyn Jones Descendants Trust 2014 (Executive Chairman) executed 3 separate sales totaling 70,751 shares for $2,926,610.17 at a blended average price of $41.36. This follows a consistent pattern: the insider's 5 prior sales at GSHD all showed negative 90-day returns (ranging from -19.4% to -22.7%), achieving a 100% well-timed rate at the 90-day mark. Cross-ticker, the insider's track record spans 20 prior sells with a 90-day well-timed rate of 100.00%. The timing context is material: GSHD's stock is currently -63.0% from its 52-week high of $114.76, down -4.9% over the past 30 days. With a P/E of 29.51, revenue growth of +16.2%, and quarterly net income of $4,889,000.00, the company's valuation and fundamentals provide the backdrop against which this sale activity should be evaluated.

General Counsel Thornthwaite Martin Ellis bought 5,000 shares of GSHD at $41.50; stock down -63.3% from 52-week high of $114.76. Two other insiders also purchased within 14 days.

Thornthwaite Martin Ellis, General Counsel, purchased 5,000 shares at $41.50 for a total value of $207,500.00, establishing an initial position in GSHD. The transaction occurred when the stock was trading -63.3% below its 52-week high of $114.76, and the stock has declined -16.8% over the past 90 days. Beyond this single executive's activity, 2 other insiders also bought within the past 14 days, creating a cluster pattern of insider purchases. The company reports strong fundamentals with annual revenue growth of +16.2% and a market cap of $891.1M, though the P/E of 29.26 remains elevated relative to the current price movement.

Jones Mark E. Jr. (President & COO) bought 2,650 shares of GSHD at $37.50; stock down -67.2% from 52-week high of $114.76.

Jones Mark E. Jr., President & COO of Goosehead Insurance, purchased 2,650 shares at $37.50 on 2026-05-15, increasing his holdings from 4,364 to 7,014 shares. The purchase occurs at $37.50 while the current price is $37.65, but the stock has declined -67.2% from its 52-week high and -8.6% over the prior 30 days. Examining his prior trading activity at this ticker, across 5 previous buys, none demonstrated positive 90-day returns—a 0% win rate at GSHD. His broader cross-ticker track record shows 5 prior buys with an average 90-day return of -10.6% and a 0.00% win rate. The timing and persistence of purchases despite consistent underwater outcomes warrants scrutiny of whether this reflects genuine conviction or a mechanical rebalancing pattern detached from near-term stock performance.

CEO Mark Miller buys 5.0K GSHD shares at $36.89 amid -67.2% pullback from 52-week high.

Mark Miller, President and CEO, purchased 5,000 shares at $36.89 on 2026-05-14, expanding his holdings from 35,000 to 40,000 shares. The transaction occurred when GSHD was down 67.2% from its 52-week high of $114.76 and down 8.6% over the prior 30 days, suggesting the CEO acted during a period of material stock weakness. Examination of his same-ticker history at GSHD reveals a 4 of 5 prior trades were well-timed at the 90-day mark, including a buy on 2024-04-29 that returned +52.5% over 90 days, indicating a pattern of favorable entry points at this specific security. The current P/E of 26.15 and annual revenue growth of +16.2% show fundamentals have not deteriorated sharply, positioning this purchase in a context of reduced valuations rather than obvious distress.

Director Louis Goldberg buys 5,575 shares of GSHD at $44.85; stock now $51.14, -58.7% from 52-week high

Director Louis Goldberg established a position in Goosehead Insurance by purchasing 5,575 shares at $44.85 on 2026-02-20 for $250,038.75, representing his first recorded shareholding in the company. The purchase occurs in a period of significant weakness: the stock has declined 25.1% over 30 days and 28.7% over 90 days, now trading at $51.14—58.7% below its 52-week high of $123.84. The company's fundamentals show solid operational performance with $90.4M quarterly revenue, positive net income of $7.9M, and annual revenue growth of +16.2%, though the P/E of 39.04 indicates valuation concerns relative to earnings. This acquisition by a board member during an extended sell-off warrants monitoring to determine whether it reflects conviction in long-term value or merely opportunistic entry amid temporary market dislocation.

Director McConnon Thomas sells 69,686 shares for $5,130,521.60 at GSHD; largest single reduction (-20.6%) with pattern of well-timed prior exits.

McConnon Thomas executed 2 separate sales totaling 69,686 shares for $5,130,521.60 on 2025-12-01, reducing his holding by 20.6% from 339,008 to 269,322 shares. His cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100.00%, and both his prior sales at GSHD (2025-02-28) demonstrated negative 90-day returns (-10.4% and -12.0%), indicating a consistent pattern of selling ahead of subsequent stock declines. The current share price of $75.91 is 39.8% below the 52-week high of $126.12, whereas this sale executed at an average price of $73.62, placing the transactions near the lower bound of recent valuation. His consistent prior execution—2 of 2 prior GSHD sales showing well-timed negative 90-day outcomes—aligns with this latest substantial reduction in position.